University of Arkansas, Fayetteville

ScholarWorks@UARK
Graduate Theses and Dissertations
12-2012

Expansion of Human Induced Pluripotent Stem Cells on Synthetic
Substrate in Defined Medium
Huantong Yao
University of Arkansas, Fayetteville

Follow this and additional works at: https://scholarworks.uark.edu/etd
Part of the Cell Biology Commons

Citation
Yao, H. (2012). Expansion of Human Induced Pluripotent Stem Cells on Synthetic Substrate in Defined
Medium. Graduate Theses and Dissertations Retrieved from https://scholarworks.uark.edu/etd/555

This Thesis is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion
in Graduate Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more
information, please contact scholar@uark.edu.

Expansion of Human Induced Pluripotent Stem Cells on Synthetic Substrate
in Defined Medium

Expansion of Human Induced Pluripotent Stem Cells on Synthetic Substrate in
Defined Medium

A thesis submitted in partial fulfillment
of the requirements for the degree of
Master of Science in Cell and Molecular Biology

By

Huantong Yao
University of Nankai
Bachelor of Science in Biotechnology, 2006

December 2012
University of Arkansas

ABSTRACT
Human induced pluripotent stem cells (hiPSCs) have the potential to generate patientspecific cells to treat many incurable diseases by cell replacement therapy. However, so far the
culture of hiPSCs depends greatly on feeder cells or Matrigel which has safety issues. Thus,
chemically defined substrates that could provide niches necessary for cell attachment and
proliferation are preferred for clinical application of hiPSCs. Recently, Corning Life Sciences
has developed synthetic peptide-functionalized cell culture surface, referred to as Corning®
Synthemax™ that support self-renewal and differentiation of human embryonic stem cell
(hESC). In this work, we have collaborated with Corning to investigate the attachment,
proliferation, and differentiation of hiPSCs on the Synthemax substrate. We demonstrated that
iPS cells retained stable proliferation and pluripotency marker protein expression after growing
on the Synthemax substrate for ten consecutive passages. Further examination reveals that
integrins αVβ5 mediates attachment to the substrate. Moreover, we observed hiPSCs colonies
were more compact on the Synthemax surface. This may be due to less activation of β-cateninmediated Wnt signaling pathway in cells on the synthetic peptide surface. In hiPSCs grown on
the Synthemax Surface, we also found denser actin filaments in the cell-cell interface and downregulation of vinculin and up-regulation of zyxin, indicating the reorganization of cytoskeleton
structure inside cells in response to cell-matrix interaction.
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CHAPTER1 INTRODUCTION

Human embryonic stem (hES) cells are valuable for many clinical applications. The emergence
of induced pluripotent stem cell (iPSC) technology raises hope of generating patient-specific
cells for cell replacement therapy. The clinical application of these cells necessitates the
development of new technologies that enable maintaining and differentiating these cells under
chemically-defined or xeno-free conditions due to safety concerns over the use of animal-derived
products in current human pluripotent stem cell (HPSC) maintenance and differentiation systems.
This project focuses on developing xeno-free substrates for long-term HPSC maintenance and
directed differentiation for clinical applications.

1.1 Stem cells
1.1.1 Human embryonic stem
Human embryonic stem cells (hESCs) are derived from inner cell mass of blastocysts (1, 2, 3, 4)
and have the potential to be undifferentiated into any type of cells in the body as listed in Table
1. (5). They are able to self-renew indefinitely and the generation of specialized cell type
provides the potential for cell replacement therapies to replace damaged and diseased organ or
tissue in the patient’s body. Therefore, hES cell represents a promising cell source for disease
treatment using cell-based therapy, such as Alzheimer's disease (AD), Parkinson’s disease (PD),
and diabetes. In addition, hES cells can be used for drug discovery, toxicity study, gene therapy,
and basic research of development biology. Nevertheless, use of hES cells for research is
1

ethically controversial since the embryonic stem cells come from surplus of embryos during in
vitro fertilization (IVF). Immune rejection to the recipients is another major concern using hES
cells as a therapeutic source during transplantation.

Table 1 Examples for human embryonic stem cell–derived cell types (5)
Layers

Tissues and cells

Ectoderm

neural precursors, dopamine neurons, motor neurons, retinal cells,
keratinocytes melanocytes

Mesoderm

fat, cartilage, skeletal muscle, bone, blood cells, cardiomyocytes

Endoderm

prostate cells, hepatocytes, lung epithelium

1.1.2 Induced pluripotent stem cells
In 1996, a groundbreaking technology so called “Induced pluripotent stem cells technology” or
“iPS cell technology” was first publicized by Shinya Yamanaka group at Kyoto University in
Japan. This technology allows reprogramming any adult somatic cells into embryonic stem cellslike cells. The reprogrammed cells possess pluripotency as hES cells do (6, 7, 8, 9). In the iPS
cell technology, four transcription factors, Oct3/4, Sox2, c-Myc, and Klf4 were cloned into
retroviral vectors and then traduced into mouse fibroblast cells. The transduced cells showed
similar properties of hES cells in morphology, global gene-expression, epigenetic state,
teratomas formation, and differentiation ability (7). With the same procedures, Yamanaka and
his colleagues produced human iPS cells from human fibroblast cells in 2007 (8). Meantime,
2

generation of human iPS cells reprogramming was published in Science from Thomson’s group
in the United State in 2007 (9).

Clearly, the advantages of iPS cells over hES cells are 1) There are no ethical issues since there
is no needed to isolate pluripotent stem cells from an embryo. 2) There is no concern about
immune rejection to the recipients in cell- or organ- transplantation since the cells can be
generated directly from the patient. iPS cells can be generated by biopsy from the patient and
then reprogrammed them into pluripotent cells, followed by induced differentiation into a cell
type for realization of patient-specific cell-based therapies. Thus, iPS cells raise hopes for
treating many otherwise incurable diseases through cell replacement therapies (10, 11, 12, 13).

1.2 History of stem cell culture technology
1.2.1 Feeder layer culture
Unlike culturing many specialized cell types, culture of pluripotent stem cells including ES cells
or iPS cells is a challenge because special niches are required for adhesion, self-renewl and
induced differentiation of these cells. The spontaneous differentiation feature of these cells
makes the culture and maintenance complicated. Often, to maintain pluripotent stem cells in
undifferentiated condition is one of the major tasks in the long-term maintenance of HPSC lines.
At the early stage of hES cell culture, it was found that mouse embryonic fibroblasts (MEFs) as
a feeder layer of hES cells are essential for hES cells continuously self-renew in undifferentiated
state (3, 14). However, it is time-consuming and labor-consuming for preparing MEFs.
Importantly, the use of animal cells has great safety concerns in clinical application due to the
potential animal virus transmission.
3

Use human cells as a feeder layer for hES/iPS cell culture was also extensively investigated (15,
16, 17). Human fetal muscle (FM), fetal skin (FS), and AFT epithelial cells were used to
construct 3 feeder layers for the test of maintenance of HES3 and HES4 cells (16). The results
show that hES cells grown in the media maintained ES features including morphology of human
ES cells, the expression of stem cell surface markers, normal karyotypes and pluripotency (16).
Human foreskin feeder was used as feeder layer cells to culture three hES cell lines for more
than 42 passages and all the hES cells were maintained pluripotent features (17). Nevertheless
there is a potential of cross contamination, since the feeder layer cells are from different origins.
Thus, it is desired to develop feeder-free and serum-free culture system.

1.2.2 Feeder free culture
Currently, Matrigel from BD Biosciences is commonly used as a substrate for hES cells culture
in undifferentiated state with combination of serum-free medium without using any feeder cells.
Matrigel is a mixture of extracellular matrix proteins extracted from the Engelbreth-HolmSwarm (EHS) mouse tumor. It is rich in laminin, collagen IV, heparan sulfate proteoglycans,
entactin, nidogen and some undefined factors (18, 19, 20). Matrigel allows us to mimic the
extracellular environment in the body. In the laboratory, Matigel has to be thawed in 4 ºC before
coating to a cell culture plate for one hour to form a film on the surface of the cell culture plate.
hES cells can be cultured on Matrigel in undifferentiated state for more than 130 population
doubling (21). Cells retain normal karyotype, expression of hES cells’ markers, pluripotency and
high telomerase activity (21). On the other hand, mTeSR medium from StemCell Technology
was formulated for use with Matrige. This combination of the culture system allows maintenance
4

of hES and iPS cells in serum-free and feeder layer free conditions. Compared to feeder layer
cells, preparation of Matrigel coated surface is a relatively easy and inexpensive process.

However, as mentioned above Matrigel is an undefined mixture of ECM proteins produced from
animal tumors and there are lot-to-lot variations. In addition, animal derived product may cause
pathogenic risks. It raises significant safety concerns over Matrigel use in clinical applications.
Hence, there is a great need to develop xeno-free, synthetic surface that capable of providing
necessary stem cell niches to allow hES/hiPS cells expansion and differentiation in a xeno-free
chemically defined culture system.

1.3 Stem cell microenvironment
1.3.1 Extracellular matrix (ECM)
The extracellular matrix (ECM) in vivo contains mainly macromolecules polysaccharides,
proteins such as different types of collagens, or proteoglycans. ECM is synthesized, secreted, and
degraded by animal cells and distributed in the cell surface or between cells. The
macromolecules include collagen, laminin, fibonection, vitronectin, elastin and so on. These
substances constitute a complex network structure to support and connect the tissue structures,
and to regulate the physiological activities of the cells. Thus, ECM is an important part in animal
tissue. It determines the characteristics of connective tissues and plays an important role in cell
migration, cell differentiation, cell proliferation, and apoptosis.

5

1.3.2 Integrin
Integrins are the major proteins of cell surface receptors. They play important roles in the
mediation of the cell and extracellular matrix adhesion and transduction information from ECM
into the cell. Integrin is a heterodimer formed by α chain (120~185kD) and β chain (90~110kD).
So far 18 kinds of α subunits and 9 β subunits have been found. They constitute more than 20
kinds of different combinations of integrin. Generally, integrin proteins are transmemebrane
proteins with a short cytoplasmic domain. There are divalent cations domains in both α subunits
and β subunits regulating the activity of integrin. The divalent cations are Mg2+ which promotes
binding and Ca2+ which inhibits the binding (23, 24).

An integrin on cell surface binds to ECM macromolecules such as collagen, laminin, fibonection,
and vitronectin. The amino acid sequence Arginine-Glycine-Aspartic acid (RGD), an
adhesion motif, is the most common binding sites between integrin and ECM proteins ( 22).
Most cells express more than one kind of integrin which is involved in several life activities. For
example, duo to the adhesion ability, integrin can lead to platelet aggregation during the wound
healing. In addition, integrin is necessary for some types of cells proliferation (25, 26). If the
interaction between integrin and ECM is blocked, the cells may fail to attach and spread.

1.3.3 Stem cell niches
Stem cell fate including self-renewal, differentiation, and death is determined by the
microenvironment which is also called niches throughout cell-ECM or cell-cell interactions.
Recently, stem cell niches are described as dynamic microenvironments that govern the growth
and repair of the organism (27). For instance, a single injection of fibronectin, a glycoprotein
6

produced in the body that helps anchor cells in place, can prevent the development of chronic
pain that often develops after a spinal cord injury (SCI) (28). A one-time injection of fibronectin
(50 μg/mL) into the spinal dorsal column (1 μL/min each injection for a total of 5 μL)
immediately after SCI inhibits the development of a particular type of chronic painor pain from
pressure that would not normally cause pain-which is common in spinal cord injury patients (28).
Bone marrow mesenchymal stem cell (MSC) not only supports the bone marrow feeder
environment for hematopoietic stem cells, but also acts as a niche for itself. Cardiovascular
progenitor cell (CPC) niche plays an essential role in maintenance and expansion of CPC in
developing human and mouse hearts (29). In the ES cell differentiation and during the embryonic
development, many phenomena are related to microenvironment, such as different gradient
distribution of the protein such as SHH (sonic hedgehog), which can determine the
differentiation pathways and development of the embryonic tissue to different lineages. However,
stem cell niches and the activation of stem cells by stem cells inches are largely elusive.

1.4 Wnt Pathway
1.4.1 Overview of Wnt Pathway
Wnt/catenin signaling pathway plays a vital role in regulating cellular proliferation, cell fate
decision, and organ development (30, 31,32). It has been well understood that Wnt signals
modulate -catenin expression and activate a higher level expression of integrins (33)

Wnt is named after Wg (wingless) and Int (Integration) (34). Wingless gene was first found in
Drosophila, and plays a role in embryonic development. The adult animal body forming gene Int
was first found in vertebrates, located nearby the mouse mammary tumor virus (MMTV)
7

integration sites. Int-1 gene and the wingless gene are homological. Drosophila wingless gene
mutation can lead to the wingless deformity, and mouse mammary tumors in MMTV replication
and integration into the genome can lead to the synthesis of one or several Wnt genes. Different
Wnt and Wnt ligands are derived from the common ancestor of the various organisms. Wnts
interact with ECM molecules to elicit their functions on target cells.

1.4.2 Canonical Wnt pathway
The canonical Wnt pathway describes a series of reactions when Wnt proteins bind with Frizzled
receptor family on the cell surface, including the activation of Dishevelled receptor family of
proteins and the change of β-catenin levels in the nucleus. Dishevelled (DSH), one of the key
components of the cell membrane, is related to the Wnt receptor complex. DSH is activated after
Wnt binding to inhibit downstream protein complexes, including axin, GSK-3, and the APC
protein. Axin/GSK-3/APC complex can promote the degradation of intracellular signaling
molecules of β-catenin. When β-catenin destruction complex was inhibited, β-catenin in the
cytoplasm will be stable and part of the β-catenin will transfer into the nucleus to promote the
expression of specific genes with the TCF / LEF transcription factor family and induce Wnt
target genes (35).

1.4.3 Regulation of stem cell by canonical Wnt pathway
Wnt pathways also play important role in maintaining stem cells in undifferentiated state,
regulating proliferation of intestinal stem cells, skin stem cells and haematopoietic stem cells (36,
37, 38). Activation of canonical Wnt pathway by inhibiton of GSK3β maintains pluripotency and
self-renewal of embryonic stem cells (39). Overexpression of activated β-catenin and activation
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of Wnt pathway leads to not only self-renewal in long-term cultures in vitro, but also
enhancement of the reconstitution of haematopoietic lineages in vivo (38). Furthermore,
canonical Wnt pathway determines the fate of stem cells. It is reported that the differentiation of
neural stem cells into neuronal and glial cells were promoted by adding active Wnt3a (40). Stem
cell can differentiate into follicular without β-catenin (41). Taken together, canonical Wnt
pathway regulates not only the expansion of stem cells but also fate of stem cells.

1.5 Synthetic peptide surface
As discussed above, there are concerns of contamination and immunogenic response by the use
of mouse feeder cells or Matrigel for the culture of stem cells for clinical application, because
both of them are animal origin and have undefined factors. Thus, chemically defined substrates
that can provide niches necessary for cell attachment and proliferation are preferred for clinical
application of hES/iPS cell. To overcome these issues, development of xeno-free and
chemically-defined hES/iPS cell culture system became one of the hottest topics in tissue
engineering and regenerative medicine. In animal tissue, ECMs are an important part of niche for
maintenance and differentiation of stem cells. Some recombinant ECM proteins have already
been investigated to support survival and self-renewal of pluripotent stem cells for several
generations (42, 43, 44, 45).

Several peptides identified using phage display libraries have been shown to support hESC
expansion for three passages (46). Another approach that has been attempted is to synthesize
biologically active peptides derived from Matrigel components. Since a major element of
Matrigel is laminin, three laminin-derived active domains have also been studied for their
9

capability of supporting hESC self-renewal and proliferation. Nonetheless, these peptide-coated
substrates can only support hESC expansions in no more than three passages (47). Microarraybased high-throughput screening identified 16 chemically-defined acrylate monomers that can
support hESC expansion in no more than five passages (48). Corning Life Sciences has recently
developed synthetic peptide-functionalized cell culture surface, referred to as Corning®
Synthemax™ Surface that support self-renewal and differentiation of hES cells (45). This
synthetic peptide surface utilized acrylate, a widely used organic synthetic biomaterial, to form
fast polymerization. Acrylate-containing carboxylic acid was deposited onto culture vessel
surfaces, and then conjugated to peptides containing amines by using 1-ethyl-3-(3dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide (EDC/NHS) to form Peptideacrylate surface (PAS). Five peptides derived from five proteins, including bone sialoprotein
(BSP), vitronectin (VN), long fibronectin (sFN), short fibronectin (lFN) and laminin (LM) were
synthesized. It was found that peptide surfaces of PAS, sFN, IFN, and LN (but not BSP-PBS and
VN-PBS), maintain hES cells at normal morphology and undifferentiated state (45). Synthemax
Surface was named for the VN-PAS peptide surface developed by Corning.

The ability of Synthemax surface to support hES cells self-renewal and induced differentiation
was evaluated by Corning and Geron Corporation (45). The surface can support the hES cells
renewal (H7) for at least 12 passages with mTeSR1, Knock Out Serum-supplemented medium or
TeSR2 without any changes in stem cells characteristics such as stable doubling time, cell
viability, normal morphology and karyotype, and expression of pluripotency markers Oct4,
TRA-1-60, and SSEA4. In differentiation experiments, teratomas coprising three germ layers
(endoderm, mesoderm, and ectoderm) and embryoid bodies were formed by the differentiation of
10

H7 cultured after 8 passages on the Synthemax. In addition, Cardiomyocytes were directly
differentiated from H7 hES cells on Synthemax surface by using a protocol in previous report
(49).

However, whether this synthetic peptide surface can support growth and differentiation of hiPSC
remains elusive. A line of evidence suggests that hiPSCs and hESCs exhibit some differences,
despite similar patterns in global transcriptome assessment (45). It has been found that a subset
of 318 genes differentially expressed between these two types of (45). This small set of genes
may represent a genetic memory of the ancestor cells from which hiPSCs were derived (45).
Thus, it is critical to assess whether the Synthemax is suitable for hiPSC maintenance and
differentiation. In this work, we investigated the attachment, proliferation, and differentiation of
hiPSCs on the Synthemax Surface. The goal of this study was to determine whether hiPSCs can
be maintained over long period of time and differentiated on the Synthemax Surface.
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CHAPTER 2 MATERIALS AND METHODS

2.1 iPS cell culture
The human iPS cell line IMR90 was acquired from the Wicell Research Institute (Madison, WI).
Cells were routinely maintained on growth factor reduced Matrigel (Becton Dickinson
Biosciences, Franklin Lakes, NJ) coated dishes in a chemically defined medium mTeSR1 (Stem
Cell Technologies, Vancouver, BC, Canada) at 37 oC with 5% CO2. The culture medium was
exchanged daily. The morphology of cell colonies was examined daily and spontaneously
differentiated colonies were removed to ensure maintenance of undifferentiated state of iPS cells.
Two methods were applied to retain undifferentiated cells and remove differentiated cells. One
method is called pick-to-remove. In this method, the differentiated colonies were physically
detached from the culture dish and aspirated along with the spent media. Another method is
called pick-to-keep, where the undifferentiated cells and colonies were physically removed and
plated in a new plate. To characterize cell growth and differentiation on the Synthemax
approximately 5x104 cell/cm2 iPS cells were plated onto the Synthemax six-well plate (Corning
Inc., Corning, NY). Cells seeded in Matrigel coated six-well plate served as a control.
Microscopic imaging was performed daily to monitor cell attachment and proliferation. Cell
number was counted by Trypan-blue staining in a 24 h time interval. Cell doubling time (td) was
estimated using equation: dx/dt=µx; td=ln2/µ.
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2.2 Immunofluorescence staining
Immunofluorescence staining was performed using varied antibodies as primary antibodies and
fluorescent dye conjugates as secondary antibodies to detect protein expression. In brief, cells
were rinsed twice in 0.5ml/well ice-cold Dulbecco's Phosphate Buffered Saline (DPBS) without
Ca2+/Mg2+ (Mediatech, Inc. Manassas, VA) at room temperature and fixed by freshly made
0.5ml of 4% paraformaldehyde (Fisher Scientific, Rockford, IL) in PBS (pH 7.4) for 15 min at
room temperature with shaking, followed by three times washing with ice-cold DPBS. The
samples were incubated for 10 min with 0.5ml per well DPBS (without Ca2+/Mg2+) containing
0.5% Triton X-100 in room temperature with shaking. Cells were then washed with DPBS three
times, each for 5 min with shaking. Cells were incubated with 0.5ml per well of blocking buffer
(0.05% Tween-20, 0.1% Triton X-100, 1%BSA, 1× DPBS) for 1 hour to block nonspecific
binding of the antibodies. After blocking, cells were incubated with primary antibodies
(300µl/well) (Table 2) in blocking buffer overnight at 4oC with shaking. After washing the cells
three times in 0.5ml/well wash buffer (0.1% BSA, 1×DPBS), each for 5 min. Cells were
incubated in fluorophore-conjugated secondary antibodies in the dark for 1 hour at room
temperature with shaking. Table 2 lists all the primary and secondary antibodies used in this
study. After washing cells three times for 5 min per wash with shaking, cells were labeled with
DAPI (diaminophenylindoleas) as well to localize cell nucleus. 4 drops of VECTASHIELD
Mounting Medium with DAPI (Vector Laboratories, Inc. Burlingame, CA) were added to each
well and incubate for 1 minute. The fluorescence microscopy images were captured by the
inverted phase contrast fluorescence microscope Olympus IX71 (MVI, Avon, MA) equipped
with a highly sensitive CCD camera (Qimaging, 32-0139-104) using Slidebook imaging analysis
software 4.2. (Olympus Imaging America Inc., Center Valley, PA).
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Table 2 Primary and secondary antibodies used for immunofluorescence staining
Primary antibody company

ratio

Secondary

company

ratio

antibody
Mouse

R&D

Systems, 1:50

Goat
anti-mouse IgG

monoclonal anti- Minneapolis, MN

Sigma, St. Louis, 1:100
MO

human SOX17
rabbit

Abcam,

1:1000 donkey
anti-rabbit

Jackson Immuno

1:50

IgG

monoclonal anti- Cambridge, MA
TRITC
human FOXA2
mouse

anti- EMD

OCT4

mouse

Millipore 1:100

Billerica, MA

anti- EMD

SSEA4

Millipore 1:100

Billerica, MA

Alexa Fluor@488 Invitrogen
phalloidin
rabbit

1:200

goat anti-mouse
Alexa
Fluro 488 IgG3

1:200

Invitrogen,
Carlsbad, CA

1:40

Eugene,OR
anti- Santa

vinculin

Rabbit

goat anti-mouse
Invitrogen,
Alexa Fluro 488
Carlsbad, CA
IgG1

Cruz 1:50

Biotechnology
Inc., Santa Cruz,

anti-rabbit IgG - Sigma, St. Louis, 1:150

CA

FITC

anti-α- Sigma, St. Louis, 1:100

actinin

MO

rabbit anti-zyxin

Sigma, St. Louis, 1:100
14

MO

MO
rabbit
FAK

anti-p- Santa

Cruz 1:50

Biotechnology
Inc., Santa Cruz,
CA

2.3 Western blotting
2.3.1 Protein sample preparation
Cells were cultured on Matrigel coated and Synthemax plates for 48 h. The cells were collected
by Typsin EDTA (Mediatech, Inc. Manassas, VA) treatment followed by centrifugation at 300×g
for 5 min and washing with DPBS once. The cell pellets were lysed with lysis buffer (50 mM
Tris (pH 7.4), 150 mM NaCl, 1 mM DTT, 0.1% SDS, 1% Triton X-100, PMSF) by using a 1 ml
syringe (Becton Dickinson, Franklin Lakes, NJ) with 20G11/2 needle (Becton Dickinson,
Franklin Lakes, NJ) up and down 20 times. Cell lysates were then centrifuged at 21,000×g for 15
min at 4 oC. The supernatants were collected and protein concentration was determined using a
Pierce BCA protein assay kit (Thermo Scientific Inc., Rockford, IL). Cytoplasmic and nuclear
proteins were extracted using a kit from Thermo Scientific. The protein samples were stored at 80oC for further experiments.

2.3.2 SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis)
Certain amount of cellular protein samples were mixed with 2×Laemmli loading buffer (Bio-Rad
Laboratories, Inc., Hercules, CA) containing 5% of β-mercaptoethanol and heated at 98°C for 5
15

minutes. After heat treatment, the samples were centrifuged at 21,000 ×g for 5 min. The samples
were loaded into wells of a 4-20% Mini-Protein® Precast gel (Bio-Rad Laboratories, Inc.,
Hercules, CA) and electrophoresis was run in the Tris/Glycine/SDS running buffer (Bio-Rad
Laboratories) at 200 V for 30 min. Magic MarkTM XP Western Standard (Invitrogen, Carlsbad,
CA) was used as a protein standard.

2.3.3 Immuno blotting and detection
PVDF nitrocellulose membrane was prewetted in methonal for 1 min and then soaked in a
transfer buffer (24.8 mM Tris, 192 mM Glycine, and 20% v/v methanol). After SDS-PAGE
electrophoresis, the gel was carefully removed from the cassette and embedded into a transfer
cassette in the following order: a sponge, filter paper, 0.45 µm nitrocellulose membrane (BioRad Laboratories), the gel, filter paper, and a sponge. Protein transferring was performed in the
Tetra Cell (Bio-Rad Laboratories). The Tetra Cell was filled with a transfer buffer with an ice
box to keep membrane transferring at low temperature. Transfer was conducted at 100 V for 1
hour. After washing the membrane with Tween-PBS (1x PBS, 0.05 % Tween-20) buffer twice for
5 minutes with shaking, the membrane was incubated in a blocking buffer (1x PBS, 0.05 %
Tween-20, 5% non-fat milk) for 1 hour with shaking at room temperature. The membrane was
incubated with primary antibodies (Table 3) in blocking buffer for 1 hour or overnight at 4oC
with shaking. After three times washing with Tween-PBS buffer, the membrane was incubated
with corresponding secondary antibodies (Table 3) conjugated to horseradish peroxidase for one
hour with shaking, followed by wash three times. Lastly, the membrane was incubated for 1
minute in a Super Signal West Substrate Working Solution (Thermo Scientific Inc., Rockford,
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IL). Protein expression was detected using a Molecular Imager ChemiDoc XRS System (BioRad Laboratories) and PDQuest Analysis software from Bio-Rad Laboratories, Inc.

Table 3 Primary and secondary antibodies used for Western blotting analysis
Primary antibody company

ratio

Secondary

company

ratio

antibody
rabbit

anti- Santa

vinculin

Rabbit

Cruz 1:200

Biotechnology
Inc., Santa Cruz,

anti-rabbit

CA

HRP

IgG Sigma, St. Louis, 1:1000
MO

anti-α- Sigma, St. Louis, 1:1000

actinin

MO

rabbit anti-zyxin

Sigma, St. Louis, 1:1000
MO

Rabbit antihuman
β-catenin

Sigma, St. Louis, 1:2000
MO

2.4 Integrin blocking assay
In order to examine the involvement of intgrins in cell attachment in the synthetic peptide
surface (50), IMR90 cells were detached by dispase treatment followed by gentle scraping.
Collected cells were washed by CMRL-BSA medium containing L-glutamine, pyruvate, 0.35%
BSA, CMRL 1066 (Mediatech, Inc. Manassas, VA). Approximately 70,000 cells were incubated
in the presence of or absence of anti- human integrin antibodies in 1 ml CMRL-BSA medium. A
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total of six samples were carried out. They were control (without antibody), anti-α5, anti-β1, antiα6, anti-αVβ5, and anti- all the 4 antibodies (total). 10 µg of 1mg/ml integrin antibodies (EMD
Millipore Billerica, MA) were added to each sample. For the total of 4 antibodies mixture, 10 µg
of each type of anti-integrin antibodies were used. The cells were then seeded to the wells of
Synthemax plate and cultured for 1 h at 37oC in cell culture CO2 incubator. Cells were also
seeded to Matrigel-coated plate for comparison. After incubation, cells were washed 3 times by
CMRL-BSA medium, followed by fixation using 100% ethanol (0.5 ml/well) for 5 minutes.
Cells were then stained by 0.4% crystal violet in methanol (0.5 ml/well) for 5 minutes and
washed by deionized H2O at least 5 times. At least 7 regions were randomly selected and colony
numbers were counted under a microscopy using the 10x objective lens. Images were taken by
an inverted phase contrast fluorescence microscope Olympus IX71 equipped with a highly
sensitive CCD camera and Slidebook imaging analysis software 4.2 (Olympus Imaging America
Inc., Center Valley, PA). The experiments were repeated at least three times independently.

2.5 Definitive endoderm differentiation from human iPS cell
Differentiation of IMR90 cells into definitive endoderm (DE) was conducted as described in our
previous work (51). Briefly, cells were seeded onto Synthemax plate and cultured in the mTeSR1
medium. Cells were fed with differentiation medium when cells reached 40-50% confluence. DE
medium contains of RPMI1640, nonessential amino acids, sodium pyruvate, B27 (Invitrogen),
1mM sodium-butyrate (Sigma), and 4 nM activin A. After 24 hour of differentiation, sodium
butyrate concentration was reduced to 0.5mM in the differentiation medium. The medium was
exchanged every other day until day 7 post differentiation.
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2.6 Quantitative real time–polymerase chain reaction (qRT-PCR) analysis
To detect the expression of two DE marker genes, SOX17 and FOXA2, in DE tissue
differentiated from iPS cells, total RNA were extracted from the cells using a RNA extraction kit
RNeasy Plus Mini from QIAGEN (Valencia, CA). TaqMan qRT-PCR was performed using
QuantiTecT Muptiplex RT-PCR NR Kit (Qiagen) according to the manufacturer’s protocol. The
cyclophilin (Applied Biosystems, University Park, IL), a human housekeeping gene, was served
as endogenous control for normalization. RNA from adult human pancreata (Stratagene, La
Jolla, CA) was used for comparison and normalization to detect relative mRNA expression level
of DE cells.

No reverse transcription control, and no template control samples were also

performed to ensure the absence of genomic DNA amplification in the qRT-PCR assay and no
false positive signal produced in the detection and analysis. The primer-probe pairs (52) were
used as below:
Sox17 forward (5’ to 3’): CAGCGAATCCAGACCTGCAGACCTGCA,
Sox17 reverse (5’ to 3’): GTCAGCGCCTTCCACGACT,
Sox17-probe (5’FAM to 3’-Tam): ACGCCGAGGGCTACTCCTCC

Foxa2 forward (5’ to 3’): CCGACTGGAGCAGCTACTATG,
Foxa2 reverse (5’ to 3’): TACGTGTTCATGCCGTTCAT,
Foxa2- probe (5’FAM to 3’-Tam): CAGAGCCCTCGGCACTGCC

2.7 Statistical analyses
Data were presented as mean ± standard deviation. The statistical analysis was performed based
on the Student’s t-test using a one-tailed algorithm. The significance was determined at p 0.05.
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CHAPTER 3 RESULTS AND DISCUSSION

3.1 Characterization of iPS cells attachment and proliferation on synthetic peptide surface
To evaluate the attachment and proliferation of iPS cells on synthetic peptide surface, iPS cells
IMR90 were seeded on the Synthemax plate. Cells grown on a Matrigel coated conventional
tissue culture plate served as a control for comparison. We observed that cell attachment time is
different between the two types of surfaces. The cells on Synthemax surface need more time to
attach to the surface. After culture for 2 days, colony morphology of cells on synthetic peptide
surface were more round compared with that on Matrigel coated surface (Fig.1). Also the
colonies grown on Synthemax plate are smaller throughout the culture.

MG

SM

Figure1. IMR90 cell colony grown on Matrigel (MG) and Synthemax surface (SM).
Fig.2 shows a typical time course of iPS cell proliferation on both Matrigel- and synthetic
peptide-coated surfaces. In these experiments, approximately 5x104 cell/cm2 IMR90 cells were
seeded into a well of Synthemax surface modified six-well plate. The same number of cells were
used to seed to a Matrigel coated six-well plate. As shown in Fig. 2, the kinetics of cell growth
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indicated that cells grown on Synthemax are equivalent to that on Matrigel. Equation 1 was used
to calculate the doubling time:
X=X0eµt (1)
Where X is the amount of cells; X0 is the amount of cells at time 0; µ is the specific growth rate;
t is the culture time.
Ln(X) =Ln(X0) +µt

(2)

When X= 2X0,
So,

doubling time= Ln2/µ

(3)

By counting cell number X and X0, µ can be obtained from the slope of the linear equation. After
substituting µ to the equation, doubling times can be calculated by Equation 3. Accordingly, the
doubling times of cells on Synthemax and Matrigel coated plate are 44.05±1.45 hours and
42.98±7.86 hours, respectively. The results suggested that there is no significant difference in
specific growth rate when cells are grown on Synthemax and Matrigel surfaces. However, we
observed that the colonies on Matrigel are bigger than on Synthemax. This was verified with
immunofluorescence staining results described in Fig. 11 &12.
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A

B

Figure 2. (A) Growth curve of iPS cells on Synthemax and Matrigel-coated plates. (B)
Estimation of the specific growth rate µ. Three independent experiments were conducted to
calculate the slope µ.
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In another experiment, we tested cell proliferation capacity on Synthemax surface. As shown in
Fig. 3, after culture cells on the Synthemax for more than three days, cells reached exponential
proliferation phase with approximately 14 million cells at day 6 in a well of six-well plate. No
differentiated cell colonies were found. It should be pointed out that cells expanded on Matrigelcoated surface have to be subcultured on day 3~4 after plating, as relative larger colonies formed
on the Matrigel coated surface on day 3~4 and colony-colony merge should be avoided in order
to prevent cells from spontaneous differentiation. While cell colonies are smaller on Synthemax
surface, which allows expansion of iPS cells for longer time before subculture. For this reason,
we were only able to examine Matrigel-coated surface culture by 4 days of culture. The result
obtained from Fig. 3 suggests that the productivity of iPS cell expansion is actually much higher
than that on Matrigel-coated surface.

Figure 3. Capability of iPS cell growth on synthetic peptide surface.
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Furthermore, in order to characterize how many passages can the synthetic peptide surface
support iPS cell self-renewal under undifferentiated state, we detected the expression of
pluripotency markers after 10 consecutive passages. High expression of stem cell specific
markers OCT4 and SSEA4 could be detected after 10 consecutive passages (Fig.4), suggesting
the cells maintained in undifferentiated state during passages. However, after 13 passages, some
spontaneous differentiation of iPS cells was observed (Fig.5). From these, we could see
Synthemax plate could maintain iPS cells in undifferentiated state over multiple passages.
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OCT4

SSEA-4

DAPI

DAPI

Merge

Merge

Figure 4. Fluorescence microscopy images of anti-OCT4 and anti-SSEA4 labeled iPS cells.
IMR90 were maintained in undifferentiated state on Synthemax surface for 10 passages. Scale
bar: 100 µm. Mouse anti-human OCT4 (1:100) and mouse anti-human SSEA4 (1:100) were used
as primary antibodies. Goat anti-mouse Alexa Fluro 488 IgG1 (1:200) and goat anti-mouse
Alexa (Alexa Fluro 488 IgG3 (1:200) were used as secondary antibodies.
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Figure 5. Distinct differentiated colonies grown on Synthemax plate after 13 passages under
bright field. Scale bar: 50 µm.
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3.2 Differentiation on Synthemax plate
We next investigated whether iPS cells retain their ability to differentiate into a specific lineage
such as a DE (Definitive endoderm) lineage. The differentiation of DE lineage is the most critical
first step in hESC pancreatic differentiation (53). Thus, demonstration of iPSC directed DE
differentiation on peptide surface could help develop a xeno-free differentiation system to
generate transplantable -cells from iPS cells for diabetes therapy. Synthemax plate has been
proved to allow differentiation of human embryonic stem cells into three germ layers (45). Here,
we examined DE differentiation of iPS cells on the Synthemax surface as we mentioned in the
Introduction that hES cells and iPS cells are identical on many aspects but not the same. As
shown in Fig. 6A, the DE morphology was observed after day 5 post induction of the
differentiation. DE marker genes, Sox17 and Foxa2 in cells differentiated on both synthetic
peptide- and Matrigel-coated surfaces after 6 days’ differentiation were analyzed by Taqman
qRT-PCR analysis. No expression of Foxa2 and Sox 17 could be detected in undifferentiated
IMR90 cells on both plates (Fig. 6B & C). Both Foxa2 and Sox 17 expressed at similar levels
and no significant difference could be observed between the differentiations on the two types of
surfaces. This experimental result indicates that Synthemax surface is as good as Matrigel coated
surface for induced differentiation of iPS cells into DE lineage. Further confirmation by
immunofluorescence (Fig. 6D) shows the expression of FOXA2 and SOX17 in differentiated iPS
cells on Sythemax. Our results indicate that the Synthemax Surface provides the appropriate
niche environment that supports both the expansion and the directed differentiation of hiPSCs.
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(A)

10×

(D)

FOXA2

20×

40×

SOX 17

DAPI

Merge

Figure 6. Definitive endoderm (DE) marker gene and protein expression in IMR90 cells
differentiated on MG and SM. (A) Morphology of DE after 6 days of differentiation. (B) Foxa2,
and (C) Sox17 mRNA expression detected by qRT-PCR. Data were presented as mean ±SD. (D)
Immunofluorescence detection of DE marker. Mouse monoclonal anti-human SOX17 (1:50) and
goat anti-mouse IgG FITC (1:100) were used as primary and secondary antibodies for SOX17.
Rabbit monoclonal anti-human FOXA2 (1:1000) and donkey anti-rabbit IgG TRITC (1:100)
were used as primary and secondary antibodies for FOXA2.
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3.3 Functional role of integrins in iPS cell attachment
Synthemax Surface is made of the VN-PAS surface as mentioned in the Introduction. It is
reported that αVβ5 integrin mediated adhesion to vitronectin (VN), so we conducted integrin
inhibition assay by blocking various integrins with anti-integrin antibodies before seeding the
cells to confirm αVβ5 mediated adhesion on Synthemax plate. Seeding cells on Matrigel coated
plates was used as control. As a result, blocking of integrin αVβ5 shows 93% inhibition of the
attachment on the Synthemax plate (Fig. 7B), but on Matrigel coated plates no significant
reduction of attachment could be detected. In addition, the blocking of integrins α5, α6, and β1
only reduced the cell adhesion to the Synthemax plate by 20, 6, and 11%, respectively. The four
integrins antibodies together nearly completely abolished the attachment of iPS cells to the
Synthemax Surface. According to the mechanism study on the cell-matrix interaction shown in
Fig. 7B, only one integrin is available for cell adhesion and spreading if an iPS cell interacts with
Synthemax surface. This is because the synthetic peptide surface was made by single peptide
sequence which was derived from vitronectin. Therefore, only integrin V5 expressed from a
cell can bind to the peptide sequence. These results are consistent with our hypothesis that
recognition of recombinant vitronectin protein by integrin αVβ5. By contrast, the cell seeded on
Matrigel coated plates has much less affection by integrin blocking. Among the integrins α5, α6,
β1 and αVβ5, integrin β1 blocking has the biggest reduction which is about 40%, meaning the role
of β1 is more important for the attachment to Matrigel. This result is consistent with the report
that integrin β1 is required for hiPSCs adhesion and proliferation on Matrigel-coated surfaces
(47). The combination of antibodies against integrins α5, α6, β1 and αVβ5 resulted in a 62%
reduction of cell adhesion to the Matrigel surface. These results suggest that multiple integrins
are involved in mediating hiPSCs adhesion to the Matrigel surface.
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Figure 7. The role of integrins in promoting iPS cell adhesion to MG and SM substrates. (A)
Micrographic images of cell attachment on SM surface without and with integrin antibodies
blocking. Scale bar: 50 mm. (B) Relative iPSC attachment on MG and SM. Data are presented as
the mean ± SD (n=14). *: p=0.037; **: p=0.0059; ***: p<0.0001. Symbols: Ab, antibody; MG,
Matrigel surface; SM, Synthemax surface. Dilution of antibodies: 1:40
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3.4 Wnt pathway
As described in the Introduction, Wnt pathway plays important roles in hES/iPS cell expansion
and differentiation. In order to investigate whether or not this important signaling pathway was
indeed affected by the substrates of surface matrix, we detected the nuclear translocation of βcatenin in iPSCs grown on SM surface and compared to MG-coated surface. Proteins in the
cytoplasm and in the nucleus were extracted separately. β-actin was used as an internal control
for the western blot assay. As revealed in Fig 8, less β-catenin was translocated from cytoplasm
to nucleus when cells were grown on SM compared with that on MG. The translocation of less βcatenin to the nucleus suggested less activation of β-catenin-mediated Wnt signaling pathway in
iPS cells grown on SM. The experimental results indicated that the lack of multiple integrins for
iPSCs attachment and proliferation may lead to the down-regulation of Wnt signaling and thus
support iPSCs proliferation in limited period of time as discussed above shown in Fig. 3, 4, and
5.
Cytoplasm
SM

MG

Nuclear
SM

MG
β-Catenin
β-actin

Figure 8. Cytoplasm and nuclear β-catenin expression in iPSCs grown on Matrigel (MG) and
Synthemax (SM) surfaces. Cytoplasm and nuclear proteins were extracted separately for Western
blot analysis. Results shown are western blotting analysis from two independent experiments.
Antibodies: Rabbit anti-human β-catenin (1:2000), anti-rabbit IgG HRP (1:1000).
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3.5 Organization of the cytoskeleton structures
Cytoskeleton plays an important role in integrin related signaling transduction pathways (54, 55).
The cytoplasmic domains of integrins bind to the cytoskeleton through adapter proteins like
vinculin, α-actinin, and phosphorylated-focal adhesion kinase (p-FAK). In order to investigate
how the substrate affects the organization of the cytoskeleton structures, we examined the
expression of cytoskeleton related proteins such as actin filaments (F-actin) and vinculin during
iPS cell proliferation on the Synthemax substrate and compared to the Matrigel-coated surface.
Due to phalloidin binds specifically at the interface between F-actin subunits we investigated Factin polymerization in iPS cells grown on the Synthemax substrate immune-stained with
phalloidin at 48 hour after culture. As shown in Fig. 9, the actin filament network of cells on
Synthemax surface is much different from that on Matrigel–coated surface. Cells grown on
synthetic peptide surface showed the accumulation of denser and broader actin filaments
between the cell-cell interfaces. Vinculin is another cytoskeletal protein that is involved in
linkage of the cytoplasm to the focal adhesions. Expression of vinculin on both types of
substrates was shown in the Fig.10A & B. Western blot analysis revealed low level of vinculin
expression in cells grown on Synthemax surface (Fig. 13A).
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(A) MG (40x)

(B) SM (40x)

DAPI

F-actin

Merge

Figure 9. Micrographic images of F-actin expression in cells grown on MG (A) and SM (B)
surface. Scale bar: 50µm. Magnification: 40×. Antibody: Alexa Fluor 488 phalloidin (1:40).
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(A) MG (20x)

(B) SM (20x)

DAPI

Vinculin

Merge

Figure 10. Micrographic images of vinculin expression in cells grown on MG (A) and SM (B)
surface. Scale bar: 100µm. Magnification: 20×. Rabbit anti human vinculin (1:50) and mouse
anti-rabbit IgG –FITC (1:150) were used as primary and secondary antibodies.
.
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In addition, we found that there is a higher expression of zyxin protein in cells grown on
Synthemax surface (Fig. 11). Western blot assay revealed a significant up-regulation of zyxin in
cells grown on the Synthemax surface (Fig. 13C). Zyxin is a zinc-binding phosphoprotein that
concentrates at focal adhesions and along the actin cytoskeleton. Since zyxin is directly involved
in cell spreading and proliferation and is inversely correlated to differentiation (56), the upregulation may contribute to cell attachment and proliferation on the Synthemax surface.
Moreover, we examined α-actinin expressions in cells grown on the Synthemax and Matrigel
substrates (Fig.12) and we observed nearly similar level of α-actinin expressions on both types of
surfaces. In the attempt of studying role of p-FAK on iPS cell-synthetic peptide surface
interaction, significant difference of p-FAK expression were not be detected between the cells
cultured on Matrigel and Synthemax surfaces (Fig. 14). While the mechanism of these changes
in cell cytoskeletal proteins is unclear, it may indicate a reorganization of cellular molecules and
focal adhesions, which facilitates the spreading and self-renewal of iPS cells on substrates, such
as peptide surface used in this work.
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Figure 11.Micrographic images of Zyxin expression in cells grown on MG (A&C) and SM
(B&D) surface. Scale bar: 100µm for A&B; 50µm for C&D. Magnification: 20× for A&B; 40×
for C&D. Rabbit anti human zyxin (1:100) and mouse anti-rabbit IgG –FITC (1:150) were used
as primary and secondary antibodies.
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(B)SM
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(D)SM
Figure 12.Micrographic images of α-actinin expression in cells grown on MG (A&C) and SM
(B&D) surface. Scale bar: 100µm for A&B; 50µm for C&D. Magnification: 20× for A&B; 40×
for C&D. Rabbit anti human α-actinin (1:100) was used as primary antibodies and mouse antirabbit IgG –FITC (1:150) as secondary antibodies.
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Figure 13. Cytoskeletal protein expression in iPS cells grown on Matrigel (MG) and Synthemax
(SM) surfaces. Cells were harvested at 48 h post seeding and total proteins were extracted for
Western blot analysis. (A-C) Vinculin, α-actinin, and zyxin expression detected by Western blot
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analysis and relative protein expression using β-actin as a loading control respectively. Semiquantification of protein expression was performed by Kodak 1D gel imaging software. At least
three independent experiments were performed and data were presented as mean ± SD. Rabbit
anti-human vinculin (1:200), rabbit anti-human α-actinin (1:1000), rabbit anti-human zyxin
(1:1000) were used as primary antibodies, respectively. Mouse anti-rabbit IgG HRP (1:1000)
was used as secondary antibodies. Bands shown are representative results from three
experiments.
(A)MG (20x)

(B)SM (20x)

p-FAK

DAPI

Merge
Figure 14.Micrographic images of p-FAK expression in cells grown on MG (A) and SM (B)
surface. Scale bar: 100µm. Magnification: 20×. Rabbit anti-human p-FAK (1:50) and mouse
anti-rabbit IgG –FITC (1:150) antibodies were used as primary and secondary antibodies.
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CHAPTER 4 CONCULSION AND FUTURE WORKS

In this work, the attachment, proliferation, and induced differentiation of human iPS cells on
Synthemax surface was evaluated and characterized. iPS cells colonies grown on Synthemax
substrate exhibited less spreading and more compact morphology compared to colonies grown
on Matrigel. We demonstrated that iPS cells retained stable proliferation and pluripotency
marker protein expression after growing on the Synthemax substrate for ten consecutive
passages. Further examination of cell-ECM interaction confirmed that iPS cells grown on the
Synthemax surface primarily utilize αVβ5 integrin to mediate attachment to the substrate, since
the Synthemax surface contains peptide sequences derived from vitronectin protein.
Investigation of β-catenin revealed less activation of β-catenin-mediated Wnt signaling pathway
on the Synthemax surface which might be the reason that the iPS cells colonies were more
compact. The cytoskeleton characterization of iPS cells grown on the Synthemax surface
revealed the formation of denser actin filaments in the cell-cell interface. The down-regulation of
vinculin and up-regulation of zyxin expression were also observed in iPS cells grown on the
Synthemax surface. Taken together, our experimental results suggest that Synthemax surface in
combination with defined medium can provide a defined culture system for expansion of clinical
grade human iPS cells for cell therapy applications.

In the future, further experiments such as teratomas forming from injection of long term cultured
iPS cells on Synthemax surface to mice can be done to further confirm Synthemax surface
performance on the maintenance of pluripotency of iPS cells. Importantly, as shown in Fig. 5,
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we found that spontaneous differentiation of iPS cells became uncontrollable after more than 12
passaging on Synthemax surface. By contrast, iPS cells can be maintained in undifferentiated
state for more than 40 passages on Matrigel-coated surface. The experimental result is
consistence with other group’s data (45). As Matrigel is a mixture of animal ECM proteins, it
seems like multiple integrins expressed on the surface of iPS cell are able to bind to distinct
ECM proteins of Matrigel, which provides to an iPS cell strong adhesion and spreading
microenvironment. Therefore, as a future direction of developing chemically-defined synthetic
peptide surface, multiple peptide sequences derived from various biological functional ECM
proteins should be coated on a culture surface for long-term expansion and induced
differentiation of hES/iPS cells. Moreover, to thoroughly investigate cellular cytoskeleton
structure and reorganization on synthetic peptide substrate, 100x or 63x objective lens are
essential for the study. Due to the pre-coating of the synthetic peptide on a six-well plate of
Synthmax plate, we were unable to use a 100x objective lens to characterize the cytoskeleton
structures. With the advent of self-coating peptide for HPSC self-renewal and induced
differentiation, further investigation on the mechanism of cell-matrix interaction and cell fate
affected by synthetic peptide substrates can be implemented.
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APPENDIX

5.1 Extraction of cytoplasmic and nuclear protein
1. Harvest with trypsin-EDTA and then centrifuge at 500 × g for 5 minutes
2. Wash cells by suspending the cell pellet with PBS.
3. Transfer 1-10 × 106 cells to a 1.5mL microcentrifuge tube and pellet by centrifugation at
500 × g for 2-3 minutes.
4. Use a pipette to carefully remove and discard the supernatant, leaving the cell pellet as
dry as possible.
5. Add ice-cold CER I to the cell pellet (Table 1). Proceed to cytoplasmic and nuclear
protein extraction, using the reagent volumes indicated in Table 1.

6. Vortex the tube vigorously on the highest setting for 15 seconds to fully suspend the cell
pellet. Incubate the tube on ice for 10 minutes.
7. Add ice-cold CER II to the tube.
8. Vortex the tube for 5 seconds on the highest setting. Incubate tube on ice for 1 minute.
9. Vortex the tube for 5 seconds on the highest setting. Centrifuge the tube for 5 minutes at
maximum speed in a microcentrifuge (~16,000 × g).
10. Immediately transfer the supernatant (cytoplasmic extract) to a clean pre-chilled tube.
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11. Suspend the insoluble (pellet) fraction produced in Step 9, which contains nuclei, in icecold NER.
12. Vortex on the highest setting for 15 seconds. Place the sample on ice and continue
vortexing for 15 seconds every 10 minutes, for a total of 40 minutes.
13. Centrifuge the tube at maximum speed (~16,000 × g) in a microcentrifuge for 10 minutes.
14. Immediately transfer the supernatant (nuclear extract) fraction to a clean pre-chilled tube.

5.2 Western blot
1. Cells were cultured for 48 hours on Matrigel coated plate and Synthemax plate and
detached by Typsin EDTA
2. Cells were collected by centrifuged at 300 ×g for 10 min and washed by Dulbecco’s
Phosphate buffered Saline
3. All cells were lysed with lysis buffer by using a 1 ml syringe with 20G11/2 needle up and
down 20 times.
4. Cell lysates were centrifuged with 21,000 ×g at 4 oC for 15 min.
5. Equal amount of cellular protein with 2×Laemmli loading buffer containing 5% of βmercaptoethanol were heated at 98°C for 5 minutes.
6. the samples were centrifuged at 21,000 ×g for 5 min. Proteins were loaded into a 4-20%
Mini-Protean® Precast gel.
7. Start the electrophoresis at 200 V for 35min.
8. Pre-wet membrane in transfer buffer 10 minutes before use at room temperature.
9. Cut the top right corner of a membrane and label the top left corner with the blot number.
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10. Prepare the transfer apparatus: fill the box half full with pre-cold transfer buffer. Wet
sponges and filter paper in transfer buffer.
11. Carefully transfer the gel to the filter paper, such that the top right corner is on the right
and faces away from the hinge.
12. Transfer the membrane on top of the gel to match the orientation of the gel (nicked corner
of gel to nicked corner of membrane). This ensures transfer of protein from left to right
on the membrane, with marker on the left and samples numbering up.
13. Ensure that the membrane and gel remain wet, and remove any bubbles in between them.
Complete the transfer sandwich with filter paper and sponge, then clamp the tray closed.
Close the transfer box, place it in a box filled with an ice.
14. Transfer 1 hr at 100V.
15. Perform blocking with PBST/5% non-fat dry milk and incubate for 2h, shaking at room
temperature.
16. Incubate with primary antibody overnight
17. . Wash the membrane 3 times with 1×PBST, 5 min each time
18. Incubate the membrane scond Antibody Peroxidase Conjugated (1:2000 in PBST/5%
non-fat dry milk, v/v) for 1 hour
19. Wash the cells 3 times with PBST, 5 min each.
20. Mix the two substrate components at a 1:1 ratio to prepare the substrate Working Solution
and incubate membrane 1 minute in the prepared Super Signal West Substrate Working
Solution.
21. Analyze the membrane and take images.
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5.3 Immunofluorescent staining
1. Rinse cells briefly twice in 0.5ml/well ice-cold PBS w/o Ca2+/Mg2+ at room temperature.
2. Fix the samples in freshly made 0.5ml/well 4% paraformaldehyde in PBS pH 7.4 for 15
min at room temperature with shaking.
3. Wash the samples three times with 0.5ml/well ice-cold PBS.
Note: The cells can be stored in 0.02% (w/v) sodium azide in PBS at 4°C for several
days.
4. Incubate the samples for 10 min with 0.5ml/well PBS w/o Ca2+/Mg2+ containing 0.5%
Triton X-100 (in room temperature) with shaking.
5. Wash cells in 0.5ml/well PBS three times, each for 5 min with shaking.
6. Block: incubate cells with 0.5ml/well blocking buffer (5% sheep serum, 5% donkey
serum, 0.05% Tween-20, 0.1% Triton X-100 in PBS) for 1 hour to block nonspecific
binding of the antibodies (10% serum from the species that the secondary antibody was
raised in) with shaking.
7. Incubate cells in 150µl/well mixture of two primary antibodies in blocking buffer
overnight at 4oC with shaking.
8. Decant the mixture solution and wash the cells three times in 0.5ml/well wash buffer,
each for 5 min with shaking.
9. Dilute the fluorophore-conjugated secondary antibody/antibodies, away from light, in
blocking buffer. Be sure that the correct isotype-specific secondary antibody for each
primary antibody is used.
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10. Incubate cells with 150µl/well mixture of two secondary antibodies which are raised in
different species with two different fluorochromes (FITC-conjugated sheep against
mouse and TRITC-conjugated donkey against rabbit) in blocking buffer for 1 hr at room
temperature in dark with shaking.
11. Decant the mixture of the secondary antibody solution and wash three times with PBS
each for 5 min in dark with shaking.
12. 4 drops of VECTASHIELD Mounting Medium with DAPI were added to each well and
incubate for 1 minute.
13. Visualize the cells using a fluorescence microscope equipped with the appropriate filters
for different dyes and take images.

5.4 Integrin blocking assay
1. Detach IMR 90 cells by dispase and collect them in the 1.5 mL tube.
2. Wash the cells by CMRL-BSA medium.
3. Count cell numbers and add 70,000 cells in each tube with 1 ml CMRL-BSA medium.
4. Add 10 µl integrin antibodies to each tube.
5. Seeding on the plates and incubate at 37 oC in CO2 incubator. After incubation until the
cells attach to the plates.
6. Wash cells by CMRL-BSA medium for 3 times
7. Fix by 0.5 ml/well100% ethanol for 5 minutes.
8. Stain the cells by 0.5 ml/well 0.4% crystal violet in methanol for 5 minutes
9. Wash the wells by dd H2O twice.
10. Take Images count the colony numbers.
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5.5 Purification of total RNA from animal cells using spin technology
1. Carefully remove all medium by aspiration and wash twice by DPBS.
2. Cells lysed directly by adding 600 µL Buffer RLT.
3. Use pipet to mix and detach the cells and transfer to a new tube.
4. Pass the lysate at least 5 times through a blunt 20G11/2 needle fitted to an RNase-free
syringe.
5. Add 1 volume of 70% ethanol to the homogenized lysate, and mix well by pipetting.
6. Transfer up to 700 μl of the sample, including any precipitate that may have formed, to
an RNeasy spin column placed in a 2 ml collection tube (supplied). Close the lid gently,
and centrifuge for 15 s at ≥8000 x g (10,000 rpm). Discard the flow-through.
7. Add 700 μl Buffer RW1 to the RNeasy spin column. Close the lid gently, and centrifuge
for 15 s at ≥8000 x g (10,000 rpm) to wash the spin column membrane. Discard the flowthrough
8. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge
for 15 s at ≥8000 x g (10,000 rpm) to wash the spin column membrane. Discard the flowthrough
9. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and centrifuge
for 2 min at ≥8000 x g (10,000 rpm) to wash the spin column membrane.
10. Place the RNeasy spin column in a new 1.5 ml collection tube. Add 30–50 μl RNase-free
water directly to the spin column membrane. Close the lid gently, and centrifuge for 1
min at ≥8000 x g (10,000 rpm) to elute the RNA.

51

5.6 Quantitative real time–polymerase chain reaction
1. Thaw 2x QuantiTect Multiplex RT-PCR NoROX Master Mix, template RNA, primer and
probe solutions, and RNase-free water. Mix the individual solutions, and place them on
ice. QuantiTect Multiplex RT Mix should be taken from –20 °C immediately before use,
always kept on ice, and returned to storage at –20 °C immediately after use.
2. Prepare a reaction mix according to Table A1 (multiplex RT-PCR using the LightCycler
2.0)

Table A1 Reaction setup for duplex on RT-PCR for other cyclers

3. Mix the reaction mix thoroughly, and dispense appropriate volumes into PCR tubes, PCR
capillaries, or the wells of a PCR plate.
4. Add template RNA to the individual PCR tubes, capillaries, or wells.
5. Program the real-time cycler according to Table A2.
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6. Place the PCR tubes, plates, or capillaries in the real-time cycler, and start the cycling
program.
7. Perform data analysis.

Table A2 PCR cycling conditions
Temperature

Time

Cycle step

50 °C

20 minutes

1cycle

95 °C

15 minutes

1cycle

94 °C

45 seconds

60 °C

45 seconds

40 cycles
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